Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04701918 | Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma | completed | Phase 2 | 9 | Massachusetts General HospitalOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT04782713 | Smart Prostate Specific Antigen (PSA) Screening Study | completed | N/A | 49 | University of Illinois at ChicagoOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers |
| completed |
| Phase 1 |
| 42 |
| Cue BiopharmaINDUSTRY |
| 1 |
| Jan 22, 2026 |
| clinicaltrials |
| NCT03503344 | Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer(PILLAR) | completed | Phase 2 | 26 | University of California, San FranciscoOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT03578406 | HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer | completed | Phase 1 | 9 | Xinqiao Hospital of ChongqingOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05470036 | Improving Germline Testing in At-Risk Patients With Prostate Cancer(IMPRINT) | completed | N/A | 50 | University of California, San DiegoOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT01810757 | Study of Weekly Radiotherapy for Bladder Cancer(HYBRID) | completed | N/A | 65 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT03556904 | FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) | completed | Phase 2 | 14 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT04763824 | KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice(KANSURVIVE) | completed | N/A | 15 | University of Kansas Medical CenterOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT05375903 | A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) | completed | Phase 1 | 51 | UroGen Pharma Ltd.INDUSTRY | 3 | Jan 14, 2026 | clinicaltrials |
| NCT06840548 | A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer(OncoCAIX) | completed | Phase 1 | 20 | Philogen S.p.A.INDUSTRY | 1 | Jan 13, 2026 | clinicaltrials |
| NCT00186368 | Microarray Analysis of Gene Expression in Prostate Tissues | completed | — | 867 | Stanford UniversityOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT07333807 | Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical Prostatectomy | completed | N/A | 60 | Tri-Service General Hospital (TSGH)OTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT03474107 | A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) | completed | Phase 3 | 608 | Astellas Pharma Global Development, Inc.INDUSTRY | 19 | Jan 9, 2026 | clinicaltrials |
| NCT04870515 | Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study | completed | N/A | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT05041257 | Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers(PICCOLO) | completed | Phase 2 | 79 | AbbVieINDUSTRY | 7 | Jan 9, 2026 | clinicaltrials |
| NCT05041504 | A Web-based Peer Navigation Program for Men With Prostate Cancer | completed | N/A | 184 | University Health Network, TorontoOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT07331246 | TENS for Pain Relief During Fusion-Guided Prostate Biopsy | completed | N/A | 84 | Medical University of GdanskOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT03996005 | MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer(MRI-TULSAP) | completed | N/A | 25 | University Hospital, Strasbourg, FranceOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT02189486 | Prostate Cancer Upgrading Reference Set | completed | — | 382 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT04897763 | Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC(PERTINENCE) | completed | Early Phase 1 | 6 | Institut Cancerologie de l'OuestOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT05707286 | Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy(ICI-PICK) | completed | — | 98 | Indiana UniversityOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT06173037 | RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer | completed | Phase 2 | 43 | RemeGen Co., Ltd.INDUSTRY | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07250178 | ONSD as an ICP Marker in vNOTES and TLH | completed | N/A | 66 | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT06429163 | Pre-incisional Wound INfiltration and Hypogastric PLEXus Block Using Ropivacaine in Laparoscopic Myomectomy(WINPLEX) | completed | N/A | 207 | Saint Petersburg State University, RussiaOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06839378 | Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei | completed | N/A | 36 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06840535 | A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer(OncoACP-3) | completed | Phase 1 | 20 | Philogen S.p.A.INDUSTRY | 1 | Jan 6, 2026 | clinicaltrials |
| NCT03734757 | Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate Cancer(DEMETER) | completed | N/A | 20 | Centre Henri BecquerelOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT04553939 | Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer | completed | Phase 2 | 50 | Henan Cancer HospitalOTHER_GOV | 1 | Jan 2, 2026 | clinicaltrials |
| NCT06016725 | Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial(E-PROOF) | completed | N/A | 75 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT00980954 | Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy | completed | Phase 3 | 236 | Radiation Therapy Oncology GroupNETWORK | 4 | Dec 31, 2025 | clinicaltrials |
| NCT01809691 | S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer(S1216) | completed | Phase 3 | 1,313 | SWOG Cancer Research NetworkNETWORK | 1 | Dec 31, 2025 | clinicaltrials |
| NCT07312825 | Effectiveness of Combined Fascial Plane Blocks for Postoperative Pain in Gynecologic Oncology Surgery | completed | — | 94 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT01823549 | Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients | completed | — | 109 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT03869216 | Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men | completed | N/A | 161 | Xavier University of Louisiana.OTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07306195 | Comparison Between High and Low Level Para-aortic Lymphadenectomy in High and Intermediate Risk Endometrial Carcinoma | completed | N/A | 150 | Ahmed AoufOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT02276924 | Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors(UROVISIO) | completed | N/A | 29 | Lille Catholic UniversityOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT02657863 | Cancer DNA Detection in Blood and Urine | completed | — | 61 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT04081636 | Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications(ProBE-PC) | completed | N/A | 840 | Albany Medical CollegeOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT04601129 | Advantage of a Fast-recovery Protocol for Minimally Invasive Kidney Surgery(RREIN) | completed | — | 60 | University Hospital, LilleOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT05483933 | Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers | completed | Phase 1 | 86 | Shattuck Labs, Inc.INDUSTRY | 4 | Dec 23, 2025 | clinicaltrials |
| NCT06783088 | Quantification With Lutetium-177 on Cadmium-Zinc-Telluride Camera 3D(QUADO) | completed | — | 20 | Central Hospital, Nancy, FranceOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT06846099 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 | completed | Phase 1 | 69 | Risen (Suzhou) Pharma Tech Co., Ltd.INDUSTRY | 1 | Dec 23, 2025 | clinicaltrials |
| NCT02985957 | A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)(CheckMate 650) | completed | Phase 2 | 351 | Bristol-Myers SquibbINDUSTRY | 10 | Dec 22, 2025 | clinicaltrials |
| NCT03027479 | Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss(METERMUS-IMC) | completed | N/A | 70 | University Hospital, ToursOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06055946 | Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy(BARVANA LONG) | completed | — | 70 | Aesculap AGINDUSTRY | 1 | Dec 22, 2025 | clinicaltrials |
| NCT02001272 | EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer(EWOC-1) | completed | Phase 2 | 120 | Hospices Civils de LyonOTHER | 6 | Dec 19, 2025 | clinicaltrials |
| NCT02485379 | Assessment of Prostate MRI Before Prostate Biopsies(MRI-FIRST01) | completed | N/A | 275 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02618200 | Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer(Echo-CAD) | completed | N/A | 2 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02651948 | Transperineal, MRI-guided, Prostate Biopsy | completed | Phase 4 | 90 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 19, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jan 22, 2026source: clinicaltrials